Curatopes Melanoma: A Database of Predicted T-cell Epitopes from Overly Expressed Proteins in Metastatic Cutaneous Melanoma.
Christopher LischerMartin EberhardtTanushree JaitlyCornelia SchinzelNiels SchaftJan DörrieGerold SchulerJulio VeraPublished in: Cancer research (2019)
Therapeutic anticancer vaccination has been adapted as an immunotherapy in several solid tumors. However, the selection of promising candidates from the total quantity of possible epitopes poses a challenge to clinicians and bioinformaticians alike, and very few epitopes have been tested in experimental or clinical settings to validate their efficacy. Here, we present a comprehensive database of predicted nonmutated peptide epitopes derived from genes that are overly expressed in a group of 32 melanoma biopsies compared with healthy tissues and that were filtered against expression in a curated list of survival-critical tissues. We hypothesize that these "self-tolerant" epitopes have two desirable properties: they do not depend on mutations, being immediately applicable to a large patient collective, and they potentially cause fewer autoimmune reactions. To support epitope selection, we provide an aggregated score of expected therapeutic efficiency as a shortlist mechanism. The database has applications in facilitating epitope selection and trial design and is freely accessible at https://www.curatopes.com. SIGNIFICANCE: A database is presented that predicts and scores antitumor T-cell epitopes, with a focus on tolerability and avoidance of severe autoimmunity, offering a supplementary epitope set for further investigation in immunotherapy.
Keyphrases
- adverse drug
- gene expression
- clinical trial
- small cell lung cancer
- emergency department
- monoclonal antibody
- randomized controlled trial
- multiple sclerosis
- palliative care
- open label
- magnetic resonance imaging
- magnetic resonance
- transcription factor
- study protocol
- early onset
- dna methylation
- phase ii
- electronic health record